April 13, 2023

OncoHelix and Burjeel Holdings to Bring Advanced Molecular Genetics to UAE

Through this exclusive agreement, OncoHelix and Burjeel strive to bring personalized medicine to clinics and hospitals in the UAE. News Release April 13, 2023: Abu Dhabi, United Arab Emirates: OncoHelix with Burjeel Holdings has partnered to set up a cutting-edge […]
March 20, 2023

Press Release: OncoHelix and Oxford Cancer Biomarkers Enter into a Partnership to Offer Breakthrough Cancer Genetic Screening Test to Canadians

March 20, 2023: Oxford Cancer Biomarkers (OCB) and OncoHelix today announce a new partnership to offer OCB’s advanced genetic tests in Canada for screening and detection of people at risk for colorectal cancer. Based on ground-breaking research at the University […]
March 1, 2023

Press Release: AVENIO® 324 GENE CGP PANEL – MATCHED to FoundationONE CDx IS NOW AVAILABLE IN CANADA

March 1, 2023: OncoHelix, a Canada-based organization for advanced molecular and immunology diagnostic testing, has announced the launch of AVENIO® 324 Gene CGP Panel in Canada, a somatic tumour tissue panel matched to the FoundationONE CDx test. This is the […]
September 21, 2021

Press Release: OncoHelix and Canexia Health enter in partnership to offer Precision Oncology genomic testing to Canadians

Calgary, AB; September 15, 2021: Two Canadian innovative genomics diagnostic companies, OncoHelix and Canexia Health, are partnering to help Canadian cancer patients gain access to precision genomic testing via their oncologist. Using a circulating tumour DNA (ctDNA) or “liquid biopsy” […]